Selected article for: "antiviral drug discovery vaccine design and drug discovery"

Author: Suthar, Mehul S.; Pulendran, Bali
Title: Systems analysis of West Nile virus infection
  • Cord-id: 0k49le7q
  • Document date: 2014_6_1
  • ID: 0k49le7q
    Snippet: Emerging and re-emerging mosquito-borne viruses continue to pose a significant threat to human health throughout the world. Over the past decade, West Nile virus (WNV), Dengue virus (DENV), and Chikungunya virus (CHIKV), have caused annual epidemics of virus-induced encephalitis, hemorrhagic fever\shock syndromes, and arthritis, respectively. Currently, no specific antiviral therapies or vaccines exist for use in humans to combat or prevent these viral infections. Thus, there is a pressing need
    Document: Emerging and re-emerging mosquito-borne viruses continue to pose a significant threat to human health throughout the world. Over the past decade, West Nile virus (WNV), Dengue virus (DENV), and Chikungunya virus (CHIKV), have caused annual epidemics of virus-induced encephalitis, hemorrhagic fever\shock syndromes, and arthritis, respectively. Currently, no specific antiviral therapies or vaccines exist for use in humans to combat or prevent these viral infections. Thus, there is a pressing need to define the virus-host interactions that govern immunity and infection outcome. Recent technological breakthroughs in ‘omics’ resources and high-throughput based assays are beginning to accelerate antiviral drug discovery and improve on current strategies for vaccine design. In this review, we highlight studies with WNV and discuss how traditional and systems based approaches are being used to rapidly identify novel host targets for therapeutic intervention and develop a deeper conceptual understanding of the host response to virus infection.

    Search related documents:
    Co phrase search for related documents
    • action mechanism and adaptive immune system: 1
    • action mechanism and adaptive immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • action mechanism and lymph node: 1, 2, 3
    • activation wnv infection and adaptive immunity: 1
    • adaptive immune response and lymph node: 1, 2, 3, 4, 5, 6
    • adaptive immunity and lymph node: 1, 2, 3, 4, 5, 6, 7, 8